32.00
price up icon10.31%   2.99
after-market After Hours: 31.50 -0.50 -1.56%
loading
Galecto Inc stock is traded at $32.00, with a volume of 102.69K. It is up +10.31% in the last 24 hours and up +35.59% over the past month. Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.
See More
Previous Close:
$29.01
Open:
$27.46
24h Volume:
102.69K
Relative Volume:
0.03
Market Cap:
$50.96M
Revenue:
-
Net Income/Loss:
$-38.35M
P/E Ratio:
-22.07
EPS:
-1.45
Net Cash Flow:
$-36.91M
1W Performance:
+16.53%
1M Performance:
+35.59%
6M Performance:
+855.22%
1Y Performance:
+500.38%
1-Day Range:
Value
$27.30
$32.20
1-Week Range:
Value
$24.60
$32.20
52-Week Range:
Value
$2.01
$33.60

Galecto Inc Stock (GLTO) Company Profile

Name
Name
Galecto Inc
Name
Phone
45-70-70-52-10
Name
Address
75 STATE STREET, BOSTON
Name
Employee
5
Name
Twitter
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
GLTO's Discussions on Twitter

Compare GLTO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GLTO
Galecto Inc
32.00 46.20M 0 -38.35M -36.91M -1.45
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.04 113.14B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
741.29 78.49B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
877.94 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
397.55 54.51B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
197.01 41.64B 447.02M -1.18B -906.14M -6.1812

Galecto Inc Stock (GLTO) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-01-25 Initiated Guggenheim Buy
Apr-26-21 Resumed Credit Suisse Outperform
Nov-23-20 Initiated BofA Securities Buy
Nov-23-20 Initiated Credit Suisse Outperform
Nov-23-20 Initiated SVB Leerink Outperform

Galecto Inc Stock (GLTO) Latest News

pulisher
Dec 09, 2025

Galecto (NASDAQ:GLTO) Price Target Raised to $36.00 at Guggenheim - Defense World

Dec 09, 2025
pulisher
Dec 08, 2025

Guggenheim Maintains Galecto (GLTO) Buy Recommendation - Nasdaq

Dec 08, 2025
pulisher
Dec 08, 2025

Guggenheim raises Galecto stock price target to $36 on positive ASH25 data - Investing.com Nigeria

Dec 08, 2025
pulisher
Dec 08, 2025

Galecto (GLTO) Rating Maintained by Guggenheim, Price Target Rai - GuruFocus

Dec 08, 2025
pulisher
Dec 06, 2025

Galecto (NASDAQ:GLTO) Upgraded to “Hold” at Wall Street Zen - Defense World

Dec 06, 2025
pulisher
Dec 05, 2025

Galecto (GLTO) Price Target Increased by 433.33% to 32.64 - Nasdaq

Dec 05, 2025
pulisher
Dec 03, 2025

Guggenheim Begins Coverage on Galecto (NASDAQ:GLTO) - Defense World

Dec 03, 2025
pulisher
Dec 02, 2025

Galecto, Inc. (GLTO) -5.1% in After-hours: What’s Driving the Move? - Stocks Telegraph

Dec 02, 2025
pulisher
Dec 02, 2025

Galecto, Inc. (GLTO) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Dec 02, 2025
pulisher
Dec 02, 2025

Galecto (GLTO) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 01, 2025

Guggenheim Initiates Coverage of Galecto (GLTO) with Buy Recommendation - Nasdaq

Dec 01, 2025
pulisher
Dec 01, 2025

Galecto (GLTO) Receives "Buy" Rating from Guggenheim | GLTO Stoc - GuruFocus

Dec 01, 2025
pulisher
Dec 01, 2025

Guggenheim Initiates Coverage on Galecto With Buy Rating, $32 Price Target - marketscreener.com

Dec 01, 2025
pulisher
Dec 01, 2025

Guggenheim initiates Galecto stock with Buy rating on DMR-001 potential - Investing.com

Dec 01, 2025
pulisher
Dec 01, 2025

Guggenheim initiates Galecto stock with Buy rating on DMR-001 potential By Investing.com - Investing.com India

Dec 01, 2025
pulisher
Nov 28, 2025

How Galecto Inc. stock performs after earningsJuly 2025 Sentiment & Technical Buy Zone Confirmation - moha.gov.vn

Nov 28, 2025
pulisher
Nov 27, 2025

Why Galecto Inc. stock could benefit from AI revolution2025 Key Lessons & Growth Oriented Trading Recommendations - moha.gov.vn

Nov 27, 2025
pulisher
Nov 27, 2025

Its Stock Has Paid Off Big Time For Galecto Inc - setenews.com

Nov 27, 2025
pulisher
Nov 24, 2025

Galecto (NASDAQ:GLTO) Rating Lowered to “Sell” at Wall Street Zen - Defense World

Nov 24, 2025
pulisher
Nov 21, 2025

Can Galecto Inc. stock deliver surprise earnings beatJuly 2025 Review & Reliable Price Breakout Alerts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Galecto, Inc. announced that it has received $284.999961 million in funding from a group of investors - marketscreener.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is Galecto Inc. stock gaining market shareJuly 2025 Action & Fast Momentum Stock Entry Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Galecto Inc. stock weather global recessionTrade Entry Summary & Fast Gaining Stock Strategy Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Galecto Inc. stock performs in rising dollar environmentMarket Sentiment Review & Safe Capital Growth Stock Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Galecto Inc. stock deliver consistent earnings growthMarket Sentiment Review & Safe Capital Preservation Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Galecto, Inc. (GLTO) -3.02% in Pre-market: Focus on Recent Acquisition Announcement - Stocks Telegraph

Nov 19, 2025
pulisher
Nov 19, 2025

Is Galecto Inc. stock attractive for growth ETFsJuly 2025 Price Swings & Verified Stock Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Wall Street Zen Upgrades Galecto (NASDAQ:GLTO) to Hold - Defense World

Nov 18, 2025
pulisher
Nov 17, 2025

Wall Street analysts’ outlook for Galecto Inc (GLTO) - setenews.com

Nov 17, 2025
pulisher
Nov 16, 2025

Galecto Acquires Damora Therapeutics and Secures $285 Million PIPE Investment - Global Legal Chronicle

Nov 16, 2025
pulisher
Nov 16, 2025

Will Galecto Inc. stock maintain dividend yieldJuly 2025 Volume & AI Driven Price Forecasts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Combining price and volume data for Galecto Inc.Bond Market & Consistent Profit Trade Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Will Galecto Inc. see short term momentumJuly 2025 Catalysts & Safe Entry Momentum Stock Tips - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Is Galecto Inc. meeting your algorithmic filter criteriaQuarterly Risk Review & Long-Term Capital Growth Strategies - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Small Cap Stocks To ResearchNovember 10th - MarketBeat

Nov 15, 2025
pulisher
Nov 15, 2025

Small Cap Stocks To Watch TodayNovember 11th - MarketBeat

Nov 15, 2025
pulisher
Nov 14, 2025

Galecto (GLTO) Stock Price, Quote, News & History - Benzinga

Nov 14, 2025
pulisher
Nov 14, 2025

Can Galecto Inc. stock hit analyst price targetsJuly 2025 Breakouts & AI Optimized Trade Strategies - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

What analysts say about Galecto Inc stockStock Buy Signals & Analysts Are Raving About These Shares - earlytimes.in

Nov 14, 2025
pulisher
Nov 13, 2025

Small Cap Stocks To Watch Today – November 11th - Defense World

Nov 13, 2025

Galecto Inc Stock (GLTO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Cap:     |  Volume (24h):